Tri-State Urologic Services is a clinical research site located in Cincinnati, Ohio, United States 45212.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Tri-State Urologic Services has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Prostatic Intraepithelial Neoplasia, Metastatic Castration-Resistant Prostate Cancer.
Sponsors: GTx, POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Ohio · View every site in Cincinnati
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tri-State Urologic Services has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tri-State Urologic Services has 2 clinical trials on record, with 1 currently active. Their work covers Prostatic Intraepithelial Neoplasia, Metastatic Castration-Resistant Prostate Cancer.
Tri-State Urologic Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.